A comprehensive review in COVID-19 treatment

Soheil Ebrahimpour; Zeinab   Mohseni Afshar; Arefeh   Babazadeh; Mostafa; VeneelaKrishna  Rekha Vasigala

doi:10.5937/afmnai38-26326

Soheil Ebrahimpour Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R. Iran
Zeinab Mohseni Afshar Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
Arefeh Babazadeh Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R. Iran.
Mostafa Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R. Iran.
VeneelaKrishna Rekha Vasigala Rangaraya Medical College, NTR University of Health Sciences, Kakinada, India

DOI: https://doi.org/10.5937/afmnai38-26326

Sažetak

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus strain that causes 2019 novel coronavirus (2019-nCoV) or COVID-19. This novel coronavirus is an emerging global health threat. It caused approximately 3 million confirmed cases and also more than one hundred thousand deaths in the world until April 28, 2020. There is still no vaccine or specific treatment for this virus. So far, the basis of most treatments has been supportive and the clinical efficacy for the suggested drugs is still under consideration. The purpose of this review is to summarize the ongoing treatments such as several antivirals, convalescent plasma transfusion, or adjunctive medications, with the intent of serving as a resource for should be evaluated in various clinical trials.